Sign in

You're signed outSign in or to get full access.

Tom Murphy Jr.

Director at BERKSHIRE HATHAWAY
Board

About Thomas S. Murphy, Jr.

Independent director of Berkshire Hathaway Inc. since December 19, 2022; age 65. Co‑founder and partner at Crestview Partners (since 2004) and previously a partner at Goldman Sachs & Co.; serves on the boards of New York University, NYU‑Langone Health, and the Inner‑City Scholarship Fund. Classified as independent under NYSE and SEC standards by Berkshire’s Governance, Compensation and Nominating Committee .

Past Roles

OrganizationRoleTenureCommittees/Impact
Crestview PartnersCo‑founder & Partner2004–presentPrivate equity leadership; substantial financial experience
Goldman Sachs & Co.PartnerPrior to 2004Investment banking experience

External Roles

OrganizationRoleTenureNotes
New York University (NYU)Board memberNot disclosedHigher education governance
NYU‑Langone HealthBoard memberNot disclosedHealth system oversight
Inner‑City Scholarship FundBoard memberNot disclosedNon‑profit governance
Several private companiesDirectorNot disclosedPrivate company board service

Board Governance

  • Independence: Determined independent by the Governance, Compensation & Nominating Committee .
  • Committees: Member, Governance, Compensation & Nominating Committee (with Burke, Chenault, Guyman; Guyman is Chair) .
  • Committee activity: Governance Committee met once during 2024; Audit Committee (which Murphy does not sit on) met six times .
  • Attendance: Each director attended all Board and applicable committee meetings in 2024; three independent-director sessions held in 2024 .
  • Board leadership: Lead Independent Director is Susan L. Decker .
CommitteeRole2024 Meeting Count
Governance, Compensation & NominatingMember1
AuditNot a member6
Independent Directors’ SessionsParticipant (as applicable)3

Fixed Compensation

  • Policy: Non‑employee directors receive $900 per in‑person meeting, $300 per telephonic meeting; Audit Committee members receive $1,000 quarterly; directors reimbursed for out‑of‑pocket expenses; no directors & officers (D&O) liability insurance provided .
YearFees Earned or Paid in CashNotes
2024$2,700 No equity or option grants disclosed; amount reflects meeting/committee fees per policy
2023$2,700 Consistent structure year over year

Performance Compensation

  • Berkshire discloses only cash meeting/committee fees for directors; no stock, option, or performance‑based awards are shown for directors in the Director Compensation tables .
Component20232024Performance Metrics Tied to Pay
Stock awards (RSUs/PSUs)None disclosed None disclosed None disclosed
Option awardsNone disclosed None disclosed None disclosed

Other Directorships & Interlocks

  • Public company boards: None disclosed for Murphy Jr. .
  • Governance Committee interlocks: During 2024, none of Berkshire’s executive officers served on boards/compensation committees where Berkshire directors served as executive officers; committee members (including Murphy Jr.) have not been Company officers/employees .
Company/EntityTypeRoleInterlock/Conflict Notes
NYU, NYU‑Langone Health, Inner‑City Scholarship FundNon‑profit/AcademicBoard memberNo interlocks with Berkshire management disclosed

Expertise & Qualifications

  • Substantial financial experience as private‑equity partner and former Goldman Sachs partner; adds owner‑oriented investment perspective aligned with Berkshire’s governance attributes .

Equity Ownership

  • Beneficial ownership as of March 5, 2025: 96 Class A shares; 2,125 Class B shares; each <0.1% of respective classes; no footnote indicating pledging for Murphy Jr. .
ClassShares Beneficially Owned% of ClassNotes
Class A96 <0.1% No pledging footnote disclosed
Class B2,125 <0.1% No pledging footnote disclosed

Governance Assessment

  • Strengths: Independent director with 100% attendance; member of the Governance, Compensation & Nominating Committee overseeing CEO pay and governance guidelines; personal share ownership supports alignment; frugal cash‑only director pay consistent with Berkshire culture .
  • Watch items: As a private‑equity partner, potential related‑party exposure could arise if Berkshire subsidiaries transact with Crestview portfolio companies—none disclosed in Related Persons Transactions, but monitor future proxies and 8‑Ks for any such dealings (no Murphy‑specific related transactions disclosed) . Limited formal Governance Committee meeting frequency (one in 2024) may constrain visible committee engagement cadence .
  • Structural context: Not on Audit Committee; Lead Independent Director role held by Susan L. Decker; independent‑director executive sessions held three times in 2024, indicating regular independent oversight outside full Board .

RED FLAGS: None disclosed specific to Murphy Jr. on attendance, related‑party transactions, pledging, or pay anomalies; Berkshire’s absence of D&O insurance for directors is atypical and may be viewed as a governance risk consideration from a director‑protection standpoint .